{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:41:46Z","timestamp":1793014906739,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.biopha.2017.05.084","type":"journal-article","created":{"date-parts":[[2017,5,28]],"date-time":"2017-05-28T18:16:04Z","timestamp":1495995364000},"page":"316-323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Pentoxifylline attenuates cytokine stress and Fas system in syngeneic liver proteins induced experimental autoimmune hepatitis"],"prefix":"10.1016","volume":"92","author":[{"given":"Nevien","family":"Hendawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2017.05.084_bib0005","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S1089-3261(02)00018-1","article-title":"Pathogenesis of autoimmune hepatitis","volume":"6","author":"Vergani","year":"2002","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.biopha.2017.05.084_bib0010","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1055\/s-2007-979467","article-title":"The impact of autoimmunity on hepatocytes","volume":"27","author":"Vergani","year":"2007","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.biopha.2017.05.084_bib0015","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.4049\/jimmunol.176.7.4484","article-title":"Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis","volume":"176","author":"Longhi","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2017.05.084_bib0020","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1089\/jir.2011.0065","article-title":"Cytokines in autoimmunity: role in induction, regulation, and treatment","volume":"31","author":"Moudgil","year":"2011","journal-title":"Interferon Cytok. Res."},{"key":"10.1016\/j.biopha.2017.05.084_bib0025","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1055\/s-2004-832940","article-title":"Immunologic mechanisms of alcoholic liver injury","volume":"24","author":"Thiele","year":"2004","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.biopha.2017.05.084_bib0030","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0300-483X(99)00087-6","article-title":"Pathophysiological mechanisms of TNF during intoxication with natural or man-made toxins","volume":"138","author":"Schumann","year":"1999","journal-title":"Toxicology"},{"key":"10.1016\/j.biopha.2017.05.084_bib0035","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1034\/j.1600-0528.2002.017401.x","article-title":"Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis","volume":"174","author":"Czaja","year":"2000","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.biopha.2017.05.084_bib0040","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jhep.2007.06.022","article-title":"Interferon-gamma exacerbates liver damage, the hepatic progenitor cell response and fibrosis in a mouse model of chronic liver injury","volume":"47","author":"Knight","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2017.05.084_bib0045","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/hep.21498","article-title":"IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice","volume":"45","author":"Erhardt","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2017.05.084_bib0050","first-page":"19","article-title":"Mechanism of hepatocyte apoptosis","volume":"29","author":"Cao","year":"2016","journal-title":"J. Cell Death"},{"key":"10.1016\/j.biopha.2017.05.084_bib0055","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis A review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.biopha.2017.05.084_bib0060","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3748\/wjg.v6.i5.688","article-title":"Effect of hepatocyte apoptosis induced by TNF-alpha on acute severe hepatitis in mouse models","volume":"6","author":"Zang","year":"2000","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biopha.2017.05.084_bib0065","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nm0497-409","article-title":"Essential roles of the Fas ligand in the development of hepatitis","volume":"3","author":"Kondo","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2017.05.084_bib0070","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1253\/circj.66.499","article-title":"Immunomodulatory effect of pentoxifylline in suppressing experimental autoimmune myocarditis","volume":"66","author":"Takehana","year":"2002","journal-title":"Circ. J."},{"key":"10.1016\/j.biopha.2017.05.084_bib0075","doi-asserted-by":"crossref","first-page":"731","DOI":"10.4236\/abb.2012.326094","article-title":"Pentoxifylline suppressed LPS-induced inflammatory and apoptotic signaling in neuronal cells","volume":"3","author":"Muchhala","year":"2012","journal-title":"Adv. Biosci. Biotechnol."},{"key":"10.1016\/j.biopha.2017.05.084_bib0080","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13069-015-0027-8","article-title":"Pentoxifylline immunomodulation in the treatment of experimental chronic pulmonary paracoccidioidomycosis","volume":"8","author":"Lopera","year":"2015","journal-title":"Fibrogen. Tissue Repair."},{"key":"10.1016\/j.biopha.2017.05.084_bib0085","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1177\/1756283X12450251","article-title":"Management of patients with difficult autoimmune hepatitis","volume":"5","author":"Parker","year":"2012","journal-title":"Ther. Adv. Gastroenterol."},{"key":"10.1016\/j.biopha.2017.05.084_bib0090","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/ibd.21336","article-title":"Liver diseases associated with anti-tumor necrosis factor-alpha (TNF-\u03b1) use for inflammatory bowel disease","volume":"17","author":"Coffin","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.biopha.2017.05.084_bib0095","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1111\/j.1572-0241.2004.40064.x","article-title":"A pilot trial of pentoxifylline in nonalcoholic steatohepatitis","volume":"99","author":"Adams","year":"2004","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.biopha.2017.05.084_bib0100","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1440-1746.2006.04756.x","article-title":"Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis","volume":"22","author":"Satapathy","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2017.05.084_bib0105","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.4254\/wjh.v7.i24.2551","article-title":"Role of pentoxifylline in non-alcoholic fatty liver disease in high-fat diet-induced obesity in mice","volume":"7","author":"Acedo","year":"2015","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.biopha.2017.05.084_bib0110","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3748\/wjg.v20.i2.569","article-title":"Effects of pentoxifylline on nonalcoholic fatty liver disease: a meta-analysis","volume":"20","author":"Du","year":"2014","journal-title":"World J. Gastroenterol.: WJG"},{"key":"10.1016\/j.biopha.2017.05.084_bib0115","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1665-2681(19)32035-6","article-title":"Pentoxifylline does not prevent neither liver damage nor early profibrogenic events in a rat model of non-alcoholic steatohepatitis","volume":"5","author":"Vial","year":"2006","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.biopha.2017.05.084_bib0120","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1476-5381.2011.01580.x","article-title":"Pentoxifylline aggravates fatty liver in obese and diabetic ob\/ob mice by increasing intestinal glucose absorption and activating hepatic lipogenesis","volume":"165","author":"Massart","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2017.05.084_bib0125","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/hep.1840110106","article-title":"Experimental autoimmune hepatitis: disease induction, time course and T-cell reactivity","volume":"11","author":"Lohse","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2017.05.084_bib0130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.lfs.2016.08.027","article-title":"Celecoxib attenuates depressive-like behavior associated with immunological liver injury in C57BL\/6 mice through TNF-\u03b1 and NF-\u03ba\u03b2 dependent mechanisms","volume":"163","author":"ELnahas","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2017.05.084_bib0135","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2017.05.084_bib0140","doi-asserted-by":"crossref","DOI":"10.1002\/hep.23584","article-title":"American Association for the Study of Liver Diseases, Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2017.05.084_bib0145","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.3748\/wjg.v13.i31.4249","article-title":"Inhibition of p38 mitogen-activated protein kinase attenuates experimental autoimmune hepatitis: involvement of nuclear factor kappa B","volume":"13","author":"Ma","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biopha.2017.05.084_bib0150","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF02460895","article-title":"Modifications of cellular immune responses in experimental autoimmune hepatitis in mice by maitake (Grifola frondosa)","volume":"39","author":"Kubo","year":"1998","journal-title":"Mycoscience"},{"key":"10.1016\/j.biopha.2017.05.084_bib0155","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1139\/cjpp-2014-0085","article-title":"Hepatoprotective effects of early pentoxifylline adminidtration on hepatic injury induced by concavalin A in rat","volume":"92","author":"Mohamed","year":"2014","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.biopha.2017.05.084_bib0160","first-page":"8990","article-title":"Protective effects of pentoxifylline on acute liver injury induced by thioacetamide in rats","volume":"8","author":"Luo","year":"2015","journal-title":"Int. J Clin. Exp. Pathol."},{"key":"10.1016\/j.biopha.2017.05.084_bib0165","first-page":"596","article-title":"Effect of pentoxifylline on hepatic injury caused in the rat by the administration of carbon tetrachloride or acetaminophen","volume":"57","author":"Abdel Salam","year":"2005","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.biopha.2017.05.084_bib0170","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0168-8278(94)80244-0","article-title":"Cellular expression of tumour necrosis factor alpha and interferon-gamma in the liver biopsies of children with chronic liver disease","volume":"21","author":"Hussain","year":"1994","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2017.05.084_bib0175","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1111\/j.1530-0277.2010.01309.x","article-title":"Autoimmune hepatitis induced by syngeneic liver cytosolic proteins biotransformed by alcohol metabolites","volume":"34","author":"Thiele","year":"2010","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.biopha.2017.05.084_bib0180","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1124\/dmd.113.056622","article-title":"Paradoxical attenuation of autoimmune hepatitis by oral isoniazid in wild-type and N-acetyltransferase-deficient mice","volume":"42","author":"Metushi","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.biopha.2017.05.084_bib0185","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1499-3872(11)60027-1","article-title":"Kupffer cells contribute to concanavalin A-induced hepatic injury through a Th1 but not Th17 type response-dependent pathway in mice","volume":"10","author":"Chen","year":"2011","journal-title":"Hepatob. Pancreat. Dis. Int"},{"key":"10.1016\/j.biopha.2017.05.084_bib0190","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-3083.2006.001761.x","article-title":"Effect of pentoxifylline on levels of pro-inflammatory cytokines during chronic hepatitis","volume":"63","author":"Gutierrez-Reyes","year":"2006","journal-title":"C. Scand. J. Immunol."},{"key":"10.1016\/j.biopha.2017.05.084_bib0195","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/gut.50.2.241","article-title":"Pentoxifylline downregulates profibrogenic cytokines and procollagen I expression in rat secondary biliary fibrosis","volume":"50","author":"Raetsch","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2017.05.084_bib0200","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.expneurol.2010.04.007","article-title":"Effect of thalidomide and pentoxifylline on experimental autoimmune encephalomyelitis (EAE)","volume":"226","author":"Corr\u00eaa","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2017.05.084_bib0205","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1586\/17474124.1.1.113","article-title":"Autoimmune hepatitis, part A: pathogenesis","volume":"1","author":"Czaja","year":"2007","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2017.05.084_bib0210","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/740149","article-title":"Pathophysiological significance of hepatic apoptosis","volume":"2013","author":"Wang","year":"2013","journal-title":"ISRN Hepatol."},{"key":"10.1016\/j.biopha.2017.05.084_bib0215","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/318665a0","article-title":"Characterization of receptors for human tumor necrosis factor and their regulation by gamma-interferon","volume":"318","author":"Aggarwal","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2017.05.084_bib0220","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.4049\/jimmunol.136.7.2441","article-title":"Interferon-gamma enhances expression of cellular receptors for tumor necrosis factor","volume":"136","author":"Tsujimoto","year":"1986","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2017.05.084_bib0225","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1002\/(SICI)1521-4141(199812)28:12<4398::AID-IMMU4398>3.0.CO;2-Y","article-title":"TNF-alpha and IFN-gamma render microglia sensitive to Fas ligand-induced apoptosis by induction of Fas expression and down-regulation of Bcl-2 and Bcl-xL","volume":"28","author":"Spanaus","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biopha.2017.05.084_bib0230","doi-asserted-by":"crossref","first-page":"743","DOI":"10.4049\/jimmunol.165.2.743","article-title":"TNF-alpha and IFN-gamma regulate expression and function of the Fas system in the seminiferous epithelium","volume":"165","author":"Riccioli","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2017.05.084_bib0235","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1084\/jem.20071258","article-title":"Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category","volume":"205","author":"Luger","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2017.05.084_bib0240","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1568-9972(02)00125-8","article-title":"Apoptosis and the liver: relation to autoimmunity and related conditions","volume":"2","author":"Bai","year":"2003","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.biopha.2017.05.084_bib0245","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1007\/s10620-014-3284-2","article-title":"Targeting apoptosis in autoimmune hepatitis","volume":"59","author":"Czaja","year":"2014","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.biopha.2017.05.084_bib0250","doi-asserted-by":"crossref","first-page":"G583","DOI":"10.1152\/ajpgi.00422.2005","article-title":"Mechanisms of liver injury. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways","volume":"290","author":"Schwabe","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.biopha.2017.05.084_bib0255","first-page":"RA337","article-title":"Apoptosis in liver diseases-detection and therapeutic applications","volume":"11","author":"Ghavami","year":"2005","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.biopha.2017.05.084_bib0260","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/hep.23987","article-title":"Tumor necrosis factor a sensitizes primary murine hepatocytes to Fas\/CD95-induced apoptosis in a Bim- and Bid-dependent manner","volume":"53","author":"Schmich","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2017.05.084_bib0265","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1034\/j.1600-0676.2001.021004272.x","article-title":"Apoptotic pathways in primary biliary cirrhosis and autoimmune hepatitis","volume":"21","author":"Fox","year":"2001","journal-title":"Liver"},{"key":"10.1016\/j.biopha.2017.05.084_bib0270","first-page":"S223","article-title":"Fas system and apoptosis in viral hepatitis J.Gastroenterol","volume":"12","author":"Hayashi","year":"1997","journal-title":"Hepatol"},{"key":"10.1016\/j.biopha.2017.05.084_bib0275","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0168-8278(99)80060-9","article-title":"Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity","volume":"30","author":"Zylberberg","year":"1999","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2017.05.084_bib0280","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1002\/(SICI)1521-4141(199812)28:12<4105::AID-IMMU4105>3.0.CO;2-8","article-title":"Involvement of Fas\/Fas ligand system-mediated apoptosis in the development of concanavalin A-induced hepatitis","volume":"28","author":"Tagawa","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biopha.2017.05.084_bib0285","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0006-2952(02)01606-4","article-title":"Osthole prevents anti-Fas antibody-induced hepatitis in mice by affecting the caspase-3-mediated apoptotic pathway","volume":"65","author":"Okamoto","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2017.05.084_bib0290","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1002\/eji.1830271119","article-title":"In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis","volume":"27","author":"K\u00fcsters","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biopha.2017.05.084_bib0295","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10565-006-0019-y","article-title":"Comparison of the effects of melatonin and pentoxifylline on carbon tetrachloride-induced liver toxicity in mice T","volume":"22","author":"Noyan","year":"2006","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.biopha.2017.05.084_bib0300","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.kjms.2016.05.005","article-title":"The effects of tadalafil and pentoxifylline on apoptosis and nitric oxide synthase in liver ischemia\/reperfusion injury","volume":"32","author":"Bektas","year":"2016","journal-title":"Kaohsiung J. Med. Sci."},{"key":"10.1016\/j.biopha.2017.05.084_bib0305","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1161\/01.CIR.103.8.1083","article-title":"Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study","volume":"103","author":"Skudicky","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2017.05.084_bib0310","first-page":"1","article-title":"Pentoxifylline abrogates cardiotoxicity induced by the administration of a single high dose or multiple low doses of doxorubicin in rats","volume":"9","author":"Elshazly","year":"2016","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.biopha.2017.05.084_bib0315","first-page":"601","article-title":"Pentoxifylline inhibits anti-Fas antibody-induced hepatitis by affecting downstream of CPP32-like activity in mice","volume":"4","author":"Okamoto","year":"1999","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.biopha.2017.05.084_bib0320","first-page":"465","article-title":"Inhibition of TNF-\u03b1 protects against hepatic ischemia-reperfusion injury in rats via NF-\u03ba\u03b2 dependent pathway, Naunyn Schmiedebergs Arch","volume":"385","author":"Mahmoud","year":"2012","journal-title":"Pharmacol"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217310740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217310740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T07:50:41Z","timestamp":1772265041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217310740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":64,"alternative-id":["S0753332217310740"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.05.084","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pentoxifylline attenuates cytokine stress and Fas system in syngeneic liver proteins induced experimental autoimmune hepatitis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.05.084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}